Welcome to LookChem.com Sign In|Join Free
  • or
Benzeneethanol, 4-(1-pyrrolidinyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

70730-29-9

Post Buying Request

70730-29-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

70730-29-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 70730-29-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,7,3 and 0 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 70730-29:
(7*7)+(6*0)+(5*7)+(4*3)+(3*0)+(2*2)+(1*9)=109
109 % 10 = 9
So 70730-29-9 is a valid CAS Registry Number.

70730-29-9Downstream Products

70730-29-9Relevant academic research and scientific papers

A Highly Selective Palladium-Catalyzed Aerobic Oxidative Aniline-Aniline Cross-Coupling Reaction

Matsumoto, Kenji,Takeda, Satoshi,Hirokane, Tsukasa,Yoshida, Masahiro

supporting information, p. 7279 - 7283 (2019/09/30)

The first catalytic oxidative aniline-aniline cross-coupling reaction using oxygen as the terminal oxidant is reported. Anilines possessing a pyrrolidino group can be preferentially oxidized under mild aerobic conditions and reacted with other anilines to afford a variety of nonsymmetrical 2-aminobiphenyls with high selectivities. A heterogeneous palladium catalyst is used for the dehydrogenative cross-coupling of anilines with structurally diverse arenes. This reaction does not require stoichiometric oxidants and is an economical and environmentally friendly method.

IMIDAZOLE DERIVATIVES AS IDO INHIBITORS

-

Page/Page column 156, (2011/06/11)

Presently provided are IDO inhibitors of general formulae (VII), (VIII) as shown below and pharmaceutical compositions thereof, useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease.

DIHYDRODIARYLOXAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE

-

Page 25, (2008/06/13)

The present invention provides dihydrodiaryloxazepine derivative represented by the following formula [1], analogs thereof and pharmaceutical compositions containing them. Those compounds have an excellent effect of improving functional diseases of gastro

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 70730-29-9